|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
1990-12-11
|
|
pubmed:abstractText |
The chronic fatigue syndrome (CFS) is characterized by profound fatigue, neuropsychiatric dysfunction, and frequent abnormalities in cell-mediated immunity. No effective therapy is known.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0002-9343
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
89
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
561-8
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:2146875-Adolescent,
pubmed-meshheading:2146875-Adult,
pubmed-meshheading:2146875-Double-Blind Method,
pubmed-meshheading:2146875-Drug Administration Schedule,
pubmed-meshheading:2146875-Fatigue Syndrome, Chronic,
pubmed-meshheading:2146875-Female,
pubmed-meshheading:2146875-Humans,
pubmed-meshheading:2146875-Immunoglobulin G,
pubmed-meshheading:2146875-Infusions, Intravenous,
pubmed-meshheading:2146875-Lymphocyte Activation,
pubmed-meshheading:2146875-Lymphopenia,
pubmed-meshheading:2146875-Male,
pubmed-meshheading:2146875-Middle Aged,
pubmed-meshheading:2146875-Placebos,
pubmed-meshheading:2146875-Quality of Life,
pubmed-meshheading:2146875-Social Adjustment,
pubmed-meshheading:2146875-T-Lymphocyte Subsets,
pubmed-meshheading:2146875-T-Lymphocytes,
pubmed-meshheading:2146875-T-Lymphocytes, Helper-Inducer
|
|
pubmed:year |
1990
|
|
pubmed:articleTitle |
A double-blind, placebo-controlled trial of intravenous immunoglobulin therapy in patients with chronic fatigue syndrome.
|
|
pubmed:affiliation |
Department of Infectious Diseases, Prince Henry Hospital, Sydney, Australia.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
